Board of directors

Gabriel Fitzgerald
Chairman of the board since 2021 Born: 1977
Education

MSc in Finance from the Stockholm School of Economics and University Medical studies at Linköping University.

Other current assignments

Board member of Fidelio Capital AB, and a number of subsidiaries within the Fidelio Capital AB-group, and the Group. Chairman of the board of Berghamnen AB and board member of Pencey Holding AB and Bellbox Holding AB.

Principal work experience

CEO of Fidelio Capital, Investment Manager at Nordic Capital and Associate at Carnegie Investment Bank.

Shareholding in the company

Gabriel is an ultimate beneficial owner of Fidelio Vet Holding AB, the Principal Owner of the Company.

Independent of

The Company and executive management: Yes
Major shareholders: No

Mikael Dolsten
Board member since 2021 Born: 1958
Education

PhD in tumor immunology and M.D. from the University of Lund and visiting professor at Lund University, Medical Faculty.

Other current assignments

Board member of Karyopharm Therapeutics.

Principal work experience

Chief Scientific Officer and President, Worldwide Research, Development and Medical at Pfizer, President of Worldwide R&D at Pfizer, President and Head of R&D at Wyeth Pharmaceuticals, Executive Vice President and Head of Pharmaceutical Research at Boehringer Ingelheim, Global VP at AstraZeneca.

Shareholding in the company

0 ordinary shares, 0 C shares.
Subscribed for a total of 31,354 warrants in the Company under Board LTI 2021.

Independent of

The Company and executive management: Yes
Major shareholders: Yes

Frida Westerberg
Board member since 2021 Born: 1975
Education

MSc in Finance and Business Administration from Stockholm School of Economics and a CEMS Master in International Management from Bocconi University in Milan.

Other current assignments

Board member of Hexatronic Group AB, Ework Group AB, Konstmässan Market AB, Market Art Fair Intressenter AB and Grebretsew AB. Deputy board member of Namrega AB.

Principal work experience

CEO of IP-Only, Deputy CEO and COO of SF Studios, various roles within the Bonnier Group and Associate at Goldman Sachs.

Shareholding in the company

0 ordinary shares, 0 C shares.
Subscribed for a total of 20,903 warrants in the Company under Board LTI 2021.

Independent of

The Company and executive management: Yes
Major shareholders: Yes

Martin Erleman
Board member since 2021 Born: 1983
Education

MSc in Finance from the Stockholm School of Economics.

Other current assignments

Chairman of the board of a number of subsidiaries within the Group and the Fidelio Capital AB-group, and SBC Intressenter BidCo AB and SBC Intressenter HoldCo AB. Board member of a number of subsidiaries within the Fidelio Capital AB-group, SBC Sveriges Bostadsrättscentrum AB, Southern Meadow AB, Greenfood MC AB, Greenfood AB and Acetaria Holding AB.

Principal work experience

Partner at Fidelio Capital, Investment Manager at Nordic Capital and Analyst at Goldman Sachs.

Shareholding in the company

0 ordinary shares, 0 C shares.
0 warrants.

Independent of

The Company and executive management: Yes
Major shareholders: No

Theodor Bonnier
Board member since 2021 Born: 1989
Education

BSc in Finance and Marketing from the Stockholm School of Economics.

Other current assignments

Board member of a number of subsidiaries within the Group and the Fidelio Capital AB-group, Bellbox Holding AB, TBON Invest AB, Chino BidCo ApS and Chino Holding ApS. Deputy board member of WF Simhold AB, a number of subsidiaries within the Fidelio Capital AB-group, Auxo AB and Bisslinge Finans AB.

Principal work experience

Director at Fidelio Capital.

Shareholding in the company

0 ordinary shares, 0 C shares.
0 warrants.

Independent of

The Company and executive management: Yes
Major shareholders: No

This website uses cookies for analytics and an improved browsing experience. Read more